Parenteral nutrition-associated cholestasis

A rare hepatic disease characterized by intrahepatic cholestasis and deterioration of liver function in patients receiving parenteral nutrition for extended periods of time (signs may appear as early as within the first two weeks of initiation of parenteral nutrition). The condition commonly occurs in neonates and usually resolves with transition to enteral feeding, although severe cases may progress to liver fibrosis, cirrhosis, and portal hypertension.

Also known as: PNAC

12 clinical trials for this condition and its sub-types, 5 tagged with Parenteral nutrition-associated cholestasis itself.